Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Mirum Pharmaceuticals, Inc. (MIRM) had Weighted-Average Shares Outstanding (Diluted) of 63.37M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$176.24M |
|
$-67.23M |
|
$30.35M |
|
$145.90M |
|
$218.78M |
|
$-42.54M |
|
$-23.00M |
|
$-65.54M |
|
$-65.54M |
|
$-67.23M |
|
$-67.23M |
|
$-67.23M |
|
$-67.23M |
|
$-42.54M |
|
$-34.94M |
|
63.37M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
63.37M |
$-1.06 |
|
$-1.06 |
|
| Balance Sheet Financials | |
$636.31M |
|
$2.25M |
|
$408.67M |
|
$1.04B |
|
$222.79M |
|
$750.08M |
|
$832.62M |
|
$1.06B |
|
$-10.42M |
|
$-257.81M |
|
$-10.42M |
|
64.75M |
|
| Cash Flow Statement Financials | |
$-273.01M |
|
$-171.56M |
|
$481.52M |
|
$298.17M |
|
$332.46M |
|
$34.30M |
|
$66.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
1.01 |
|
-71.97 |
|
82.78% |
|
-24.14% |
|
-24.14% |
|
-- |
|
-37.19% |
|
-38.14% |
|
$-273.70M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
1.18 |
|
1.21 |
|
74.23 |
|
645.05% |
|
26.08% |
|
-6.43% |
|
-9.09% |
|
$-0.16 |
|
$-4.32 |
|
$-4.31 |
|